{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:09:21Z","timestamp":1778659761882,"version":"3.51.4"},"reference-count":48,"publisher":"American Diabetes Association","issue":"2","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,2,1]]},"abstract":"<jats:p>OBJECTIVE\u2014Type 1 diabetes is an autoimmune disease characterized by a local inflammatory reaction in and around islets followed by selective destruction of insulin-secreting \u03b2-cells. We tested the hypothesis that chemokines affect different mechanisms responsible for the development of diabetes in NOD mice.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014We examined chemokine expression in islets of NOD mice and tested their functional relevance to development of diabetes using transgenic mice expressing the mouse herpesvirus 68\u2013encoded chemokine decoy receptor M3 (NOD-M3 mice) in insulin-secreting \u03b2-cells.<\/jats:p>\n               <jats:p>RESULTS\u2014Multiple chemokines were expressed in pancreatic islets of NOD mice before development of diabetes. Islet-specific expression of the pan-chemokine inhibitor M3 dramatically reduced leukocyte infiltration and islet destruction and completely blocked development of diabetes in NOD-M3 mice. M3 blocked diabetes by inhibiting the priming of diabetogenic cells in the pancreatic lymph nodes and their recruitment into the islets. This effect was specific to the pancreatic islets because M3 expression did not affect other ongoing autoimmune processes.<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014These results demonstrate that chemokines mediate afferent and efferent immunity in type 1 diabetes and suggest that broad chemokine blockade may represent a viable strategy to prevent insulitis and islet destruction.<\/jats:p>","DOI":"10.2337\/db07-1309","type":"journal-article","created":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T01:54:07Z","timestamp":1195091647000},"page":"387-394","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":34,"title":["Islet Expression of M3 Uncovers a Key Role for Chemokines in the Development and Recruitment of Diabetogenic Cells in NOD Mice"],"prefix":"10.2337","volume":"57","author":[{"given":"Andrea P.","family":"Martin","sequence":"first","affiliation":[{"name":"Immunology Institute, Mount Sinai School of Medicine, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos G.","family":"Grisotto","sequence":"additional","affiliation":[{"name":"Immunology Institute, Mount Sinai School of Medicine, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Canasto-Chibuque","sequence":"additional","affiliation":[{"name":"Immunology Institute, Mount Sinai School of Medicine, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"Kunkel","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan S.","family":"Bromberg","sequence":"additional","affiliation":[{"name":"Immunology Institute, Mount Sinai School of Medicine, New York, New York"},{"name":"Department of Gene and Cell Medicine, Mount Sinai School of Medicine, New York, New York"},{"name":"Recanati\/Miller Transplantation Institute, Mount Sinai School of Medicine, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glaucia C.","family":"Furtado","sequence":"additional","affiliation":[{"name":"Immunology Institute, Mount Sinai School of Medicine, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio A.","family":"Lira","sequence":"additional","affiliation":[{"name":"Immunology Institute, Mount Sinai School of Medicine, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031207590181400_R1","doi-asserted-by":"crossref","unstructured":"Foulis AK: C.L. Oakley Lecture1987. The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus. J Pathol\u2008152:141\u2013148,1987","DOI":"10.1002\/path.1711520302"},{"key":"2022031207590181400_R2","doi-asserted-by":"crossref","unstructured":"Adorini L, Gregori S, Harrison LC: Understanding autoimmune diabetes: insights from mouse models. Trends Mol Med\u20088:31\u201338,2002","DOI":"10.1016\/S1471-4914(01)02193-1"},{"key":"2022031207590181400_R3","doi-asserted-by":"crossref","unstructured":"Wicker LS, Miller BJ, Mullen Y: Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes\u200835:855\u2013860,1986","DOI":"10.2337\/diabetes.35.8.855"},{"key":"2022031207590181400_R4","doi-asserted-by":"crossref","unstructured":"Yagi H, Matsumoto M, Kunimoto K, Kawaguchi J, Makino S, Harada M: Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur J Immunol\u200822:2387\u20132393,1992","DOI":"10.1002\/eji.1830220931"},{"key":"2022031207590181400_R5","doi-asserted-by":"crossref","unstructured":"Nikolic T, Geutskens SB, van Rooijen N, Drexhage HA, Leenen PJ: Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study. Lab Invest\u200885:487\u2013501,2005","DOI":"10.1038\/labinvest.3700238"},{"key":"2022031207590181400_R6","doi-asserted-by":"crossref","unstructured":"Jun HS, Santamaria P, Lim HW, Zhang ML, Yoon JW: Absolute requirement of macrophages for the development and activation of \u03b2-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice. Diabetes\u200848:34\u201342,1999","DOI":"10.2337\/diabetes.48.1.34"},{"key":"2022031207590181400_R7","doi-asserted-by":"crossref","unstructured":"Frigerio S, Junt T, Lu B, Gerard C, Zumsteg U, Hollander GA, Piali L: Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med\u20088:1414\u20131420,2002","DOI":"10.1038\/nm1202-792"},{"key":"2022031207590181400_R8","doi-asserted-by":"crossref","unstructured":"Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, Adorini L: A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J Immunol\u2008173:2280\u20132287,2004","DOI":"10.4049\/jimmunol.173.4.2280"},{"key":"2022031207590181400_R9","doi-asserted-by":"crossref","unstructured":"Piemonti L, Leone BE, Nano R, Saccani A, Monti P, Maffi P, Bianchi G, Sica A, Peri G, Melzi R, Aldrighetti L, Secchi A, Di Carlo V, Allavena P, Bertuzzi F: Human pancreatic islets produce and secrete MCP-1\/CCL2: relevance in human islet transplantation. Diabetes\u200851:55\u201365,2002","DOI":"10.2337\/diabetes.51.1.55"},{"key":"2022031207590181400_R10","doi-asserted-by":"crossref","unstructured":"Cameron MJ, Arreaza GA, Grattan M, Meagher C, Sharif S, Burdick MD, Strieter RM, Cook DN, Delovitch TL: Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. J Immunol\u2008165:1102\u20131110,2000","DOI":"10.4049\/jimmunol.165.2.1102"},{"key":"2022031207590181400_R11","doi-asserted-by":"crossref","unstructured":"Chen MC, Proost P, Gysemans C, Mathieu C, Eizirik DL: Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells. Diabetologia\u200844:325\u2013332,2001","DOI":"10.1007\/s001250051622"},{"key":"2022031207590181400_R12","doi-asserted-by":"crossref","unstructured":"Bouma G, Coppens JM, Mourits S, Nikolic T, Sozzani S, Drexhage HA, Versnel MA: Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice. Eur J Immunol\u200835:2386\u20132396,2005","DOI":"10.1002\/eji.200526251"},{"key":"2022031207590181400_R13","doi-asserted-by":"crossref","unstructured":"Ploix C, Lo D, Carson MJ: A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity. J Immunol\u2008167:6724\u20136730,2001","DOI":"10.4049\/jimmunol.167.12.6724"},{"key":"2022031207590181400_R14","doi-asserted-by":"crossref","unstructured":"Kim SH, Cleary MM, Fox HS, Chantry D, Sarvetnick N: CCR4-bearing T cells participate in autoimmune diabetes. J Clin Invest\u2008110:1675\u20131686,2002","DOI":"10.1172\/JCI0215547"},{"key":"2022031207590181400_R15","doi-asserted-by":"crossref","unstructured":"Savinov AY, Wong FS, Stonebraker AC, Chervonsky AV: Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J Exp Med\u2008197:643\u2013656,2003","DOI":"10.1084\/jem.20021378"},{"key":"2022031207590181400_R16","doi-asserted-by":"crossref","unstructured":"Szanya V, Ermann J, Taylor C, Holness C, Fathman CG: The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol\u2008169:2461\u20132465,2002","DOI":"10.4049\/jimmunol.169.5.2461"},{"key":"2022031207590181400_R17","doi-asserted-by":"crossref","unstructured":"Jensen KK, Chen SC, Hipkin RW, Wiekowski MT, Schwarz MA, Chou CC, Simas JP, Alcami A, Lira SA: Disruption of CCL21-induced chemotaxis in vitro and in vivo by M3, a chemokine-binding protein encoded by murine gammaherpesvirus 68. J Virol\u200877:624\u2013630,2003","DOI":"10.1128\/JVI.77.1.624-630.2003"},{"key":"2022031207590181400_R18","doi-asserted-by":"crossref","unstructured":"Martin AP, Alexander-Brett JM, Canasto-Chibuque C, Garin A, Bromberg JS, Fremont DH, Lira SA: The chemokine binding protein M3 prevents diabetes induced by multiple low doses of streptozotocin. J Immunol\u2008178:4623\u20134631,2007","DOI":"10.4049\/jimmunol.178.7.4623"},{"key":"2022031207590181400_R19","doi-asserted-by":"crossref","unstructured":"Andre I, Gonzalez A, Wang B, Katz J, Benoist C, Mathis D: Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci U S A\u200893:2260\u20132263,1996","DOI":"10.1073\/pnas.93.6.2260"},{"key":"2022031207590181400_R20","doi-asserted-by":"crossref","unstructured":"Ikegami H: Animal models of autoimmune polyglandular syndrome. Endocrinol Metab Clin North Am\u200831:431\u2013439, viii,2002","DOI":"10.1016\/S0889-8529(01)00019-6"},{"key":"2022031207590181400_R21","doi-asserted-by":"crossref","unstructured":"Kikutani H, Makino S: The murine autoimmune diabetes model: NOD and related strains. Adv Immunol\u200851:285\u2013322,1992","DOI":"10.1016\/S0065-2776(08)60490-3"},{"key":"2022031207590181400_R22","doi-asserted-by":"crossref","unstructured":"Morimoto J, Yoneyama H, Shimada A, Shigihara T, Yamada S, Oikawa Y, Matsushima K, Saruta T, Narumi S: CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis. J Immunol\u2008173:7017\u20137024,2004","DOI":"10.4049\/jimmunol.173.11.7017"},{"key":"2022031207590181400_R23","doi-asserted-by":"crossref","unstructured":"Miyagawa J, Hanafusa T, Miyazaki A, Yamada K, Fujino-Kurihara H, Nakajima H, Kono N, Nonaka K, Tochino Y, Tarui S: Ultrastructural and immunocytochemical aspects of lymphocytic submandibulitis in the non-obese diabetic (NOD) mouse. Virchows Arch B Cell Pathol Incl Mol Pathol\u200851:215\u2013225,1986","DOI":"10.1007\/BF02899031"},{"key":"2022031207590181400_R24","doi-asserted-by":"crossref","unstructured":"Zhang Y, O\u2019Brien B, Trudeau J, Tan R, Santamaria P, Dutz JP: In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes. J Immunol\u2008168:1466\u20131472,2002","DOI":"10.4049\/jimmunol.168.3.1466"},{"key":"2022031207590181400_R25","doi-asserted-by":"crossref","unstructured":"Mathis D, Vence L, Benoist C: Beta-cell death during progression to diabetes. Nature\u2008414:792\u2013798,2001","DOI":"10.1038\/414792a"},{"key":"2022031207590181400_R26","doi-asserted-by":"crossref","unstructured":"Haskins K, Portas M, Bradley B, Wegmann D, Lafferty K: T-lymphocyte clone specific for pancreatic islet antigen. Diabetes\u200837:1444\u20131448,1988","DOI":"10.2337\/diabetes.37.10.1444"},{"key":"2022031207590181400_R27","doi-asserted-by":"crossref","unstructured":"Hoglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D: Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med\u2008189:331\u2013339,1999","DOI":"10.1084\/jem.189.2.331"},{"key":"2022031207590181400_R28","doi-asserted-by":"crossref","unstructured":"Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL: IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia\u200846:255\u2013266,2003","DOI":"10.1007\/s00125-002-1017-0"},{"key":"2022031207590181400_R29","doi-asserted-by":"crossref","unstructured":"Janatpour MJ, Hudak S, Sathe M, Sedgwick JD, McEvoy LM: Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment. J Exp Med\u2008194:1375\u20131384,2001","DOI":"10.1084\/jem.194.9.1375"},{"key":"2022031207590181400_R30","doi-asserted-by":"crossref","unstructured":"Chen SC, Vassileva G, Kinsley D, Holzmann S, Manfra D, Wiekowski MT, Romani N, Lira SA: Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J Immunol\u2008168:1001\u20131008,2002","DOI":"10.4049\/jimmunol.168.3.1001"},{"key":"2022031207590181400_R31","doi-asserted-by":"crossref","unstructured":"Christen U, McGavern DB, Luster AD, von Herrath MG, Oldstone MB: Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J Immunol\u2008171:6838\u20136845,2003","DOI":"10.4049\/jimmunol.171.12.6838"},{"key":"2022031207590181400_R32","doi-asserted-by":"crossref","unstructured":"Shigihara T, Shimada A, Oikawa Y, Yoneyama H, Kanazawa Y, Okubo Y, Matsushima K, Yamato E, Miyazaki J, Kasuga A, Saruta T, Narumi S: CXCL10 DNA vaccination prevents spontaneous diabetes through enhanced beta cell proliferation in NOD mice. J Immunol\u2008175:8401\u20138408,2005","DOI":"10.4049\/jimmunol.175.12.8401"},{"key":"2022031207590181400_R33","doi-asserted-by":"crossref","unstructured":"Carvalho-Pinto C, Garcia MI, Gomez L, Ballesteros A, Zaballos A, Flores JM, Mellado M, Rodriguez-Frade JM, Balomenos D, Martinez AC: Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice. Eur J Immunol\u200834:548\u2013557,2004","DOI":"10.1002\/eji.200324285"},{"key":"2022031207590181400_R34","doi-asserted-by":"crossref","unstructured":"van Berkel V, Barrett J, Tiffany HL, Fremont DH, Murphy PM, McFadden G, Speck SH, Virgin HI: Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol\u200874:6741\u20136747,2000","DOI":"10.1128\/JVI.74.15.6741-6747.2000"},{"key":"2022031207590181400_R35","doi-asserted-by":"crossref","unstructured":"Parry CM, Simas JP, Smith VP, Stewart CA, Minson AC, Efstathiou S, Alcami A: A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med\u2008191:573\u2013578,2000","DOI":"10.1084\/jem.191.3.573"},{"key":"2022031207590181400_R36","doi-asserted-by":"crossref","unstructured":"Alexander JM, Nelson CA, van Berkel V, Lau EK, Studts JM, Brett TJ, Speck SH, Handel TM, Virgin HW, Fremont DH: Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell\u2008111:343\u2013356,2002","DOI":"10.1016\/S0092-8674(02)01007-3"},{"key":"2022031207590181400_R37","doi-asserted-by":"crossref","unstructured":"Webb LM, Clark-Lewis I, Alcami A: The gammaherpesvirus chemokine binding protein binds to the N terminus of CXCL8. J Virol\u200877:8588\u20138592,2003","DOI":"10.1128\/JVI.77.15.8588-8592.2003"},{"key":"2022031207590181400_R38","doi-asserted-by":"crossref","unstructured":"van Berkel V, Levine B, Kapadia SB, Goldman JE, Speck SH, Virgin HWT: Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis. J Clin Invest\u2008109:905\u2013914,2002","DOI":"10.1172\/JCI14358"},{"key":"2022031207590181400_R39","doi-asserted-by":"crossref","unstructured":"Pyo R, Jensen KK, Wiekowski MT, Manfra D, Alcami A, Taubman MB, Lira SA: Inhibition of intimal hyperplasia in transgenic mice conditionally expressing the chemokine-binding protein M3. Am J Pathol\u2008164:2289\u20132297,2004","DOI":"10.1016\/S0002-9440(10)63785-6"},{"key":"2022031207590181400_R40","doi-asserted-by":"crossref","unstructured":"Liu L, Dai E, Miller L, Seet B, Lalani A, Macauley C, Li X, Virgin HW, Bunce C, Turner P, Moyer R, McFadden G, Lucas A: Viral chemokine-binding proteins inhibit inflammatory responses and aortic allograft transplant vasculopathy in rat models. Transplantation\u200877:1652\u20131660,2004","DOI":"10.1097\/01.TP.0000131173.52424.84"},{"key":"2022031207590181400_R41","doi-asserted-by":"crossref","unstructured":"Martin AP, Canasto-Chibuque C, Shang L, Rollins BJ, Lira SA: The chemokine decoy receptor M3 blocks CC chemokine ligand 2 and CXC chemokine ligand 13 function in vivo. J Immunol\u2008177:7296\u20137302,2006","DOI":"10.4049\/jimmunol.177.10.7296"},{"key":"2022031207590181400_R42","doi-asserted-by":"crossref","unstructured":"Levisetti MG, Suri A, Frederick K, Unanue ER: Absence of lymph nodes in NOD mice treated with lymphotoxin-\u03b2 receptor immunoglobulin protects from diabetes. Diabetes\u200853:3115\u20133119,2004","DOI":"10.2337\/diabetes.53.12.3115"},{"key":"2022031207590181400_R43","doi-asserted-by":"crossref","unstructured":"Gagnerault MC, Luan JJ, Lotton C, Lepault F: Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J Exp Med\u2008196:369\u2013377,2002","DOI":"10.1084\/jem.20011353"},{"key":"2022031207590181400_R44","doi-asserted-by":"crossref","unstructured":"Jun HS, Yoon CS, Zbytnuik L, van Rooijen N, Yoon JW: The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med\u2008189:347\u2013358,1999","DOI":"10.1084\/jem.189.2.347"},{"key":"2022031207590181400_R45","doi-asserted-by":"crossref","unstructured":"Iyoda T, Shimoyama S, Liu K, Omatsu Y, Akiyama Y, Maeda Y, Takahara K, Steinman RM, Inaba K: The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med\u2008195:1289\u20131302,2002","DOI":"10.1084\/jem.20020161"},{"key":"2022031207590181400_R46","doi-asserted-by":"crossref","unstructured":"Turley S, Poirot L, Hattori M, Benoist C, Mathis D: Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med\u2008198:1527\u20131537,2003","DOI":"10.1084\/jem.20030966"},{"key":"2022031207590181400_R47","doi-asserted-by":"crossref","unstructured":"Harbers SO, Crocker A, Catalano G, D\u2019Agati V, Jung S, Desai DD, Clynes R: Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance. J Clin Invest\u2008117:1361\u20131369,2007","DOI":"10.1172\/JCI29470"},{"key":"2022031207590181400_R48","doi-asserted-by":"crossref","unstructured":"Wells TN, Power CA, Shaw JP, Proudfoot AE: Chemokine blockers: therapeutics in the making?Trends Pharmacol Sci\u200827:41\u201347,2006","DOI":"10.1016\/j.tips.2005.11.001"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/57\/2\/387\/389744\/zdb00208000387.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/57\/2\/387\/389744\/zdb00208000387.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:13:18Z","timestamp":1667405598000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/57\/2\/387\/13107\/Islet-Expression-of-M3-Uncovers-a-Key-Role-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,1]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db07-1309","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,1]]}}}